Karien Meier, Toivo Glatz, Mathijs C. Guijt, Marco Piccininni, Merel van der Meulen, Khal |
ΰ ǥ ȣġ ڷγ̷ 罺-CoV-2 ڷγ̷ 2019(COVID-19) ߰ Ȯ ſ ߿ϴ. ȣ ġ ȿ ϰ, ̷ ġ ϸ, ິ ʱ ܰ COVID-19 ȹϴµ Ǵ ä ĺϴ ǥ Ͽ. ٱ ̿ ¶ 簡 3 19Ϻ Ǿ.
2020. 5 , 500 ̻ ڰ ִ 跮 ߴ. , 츮 ܰ ȸ ġ ߴ. 9,796 ε , 8,611 ״(3ܰ), 604 (3ܰ), 581 Ż(4ܰ) ߴ. ȭʿ ִ Žϱ , 츮 ֿ 1,365 Խ״. ڵ ģȸ , , ȣ å( å : 95.0%~99.7%) õ å Ÿ´. ״ ڴ (76.6%)̳ Ż(87.2%) ȸ ȿ(59.2%) ߴ. Ż ڵ ȸ Ÿġ (: 90.2%-99.3%, ϰ ״ : 67.5%-97.0%) ڻ ȸ Ÿ (: 36.3%-96.6%, ϰ ״ : 28.3%-95.7%) ߴ. ڵ ϱ ߺ ൿ ˰ ִٰ ߴ(:90.2%~91.1%). Ϲ Ǵ äο ڷ Ź, ǰ Ʈ, Ҽ ̵ ԵǾ ־. , 츮 信 ū ̰ ٴ ߴ. COVID-19 ʱ ܰ , ȣ ȿ 3 ġ ڴ ִٰ ߴ. 2020 3, ġ ٸ, Ⱓ ġ ū COVID-19 δ Ż ߿ Ҵ.
1 ڷγ̷
1. ڷγ̷-19(Covid-19) 7
2. ڷγ̷ з Ư 9
3. ڷγ̷ ̰ 11
4. ڷγ̷ (Covid-19 Organization) 13
5. ڷγ19: ȯ濡 ĥ? 19
6. ġ(Therapeutical Method) 22
2
Public perspectives on protective measures during the COVID-19 pandemic in the Netherlands, Germany and Italy: A survey study
1. Introduction 24
2. Survey instrument 25
3. Statistical analyses 26
4. Results 27
5. Individual implementation of protective measures 30
6. Discussion 33
7. Study strengths and limitations 34
8. Conclusion 35
9. References 37